Genome-wide pathway analysis using gene expression data of colonic mucosa in patients with inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 21, Issue 6, 2015, Pages 1260-1268

  Palmieri, Orazio ^a   Creanza, Teresa M ^b   Bossa, Fabrizio ^a   Palumbo, Orazio ^a   Maglietta, Rosalia ^b   Ancona, Nicola ^b   Corritore, Giuseppe ^a   Latiano, Tiziana ^a   Martino, Giuseppina ^a   Biscaglia, Giuseppe ^a   Scimeca, Daniela ^a   De Petris, Michele P ^a   Carella, Massimo ^a   Annese, Vito ^c   Andriulli, Angelo ^a   Latiano, Anna ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b INSTITUTE OF INTELLIGENT SYSTEMS FOR AUTOMATION   (Italy)

^c CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Crohn's disease; gene expression; inflammatory bowel disease; pathways analysis; ulcerative colitis

Indexed keywords

ARGININE VASOPRESSIN RECEPTOR 1A; ARGIPRESSIN RECEPTOR; C10ORF58 PROTEIN; CACNA2D1 PROTEIN; CARRIER PROTEIN; CRAT PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT MODULATOR; GJB1 PROTEIN; GNG2 PROTEIN; HEPATOMA DERIVED GROWTH FACTOR; HEPATOMA DERIVED GROWTH FACTOR RELATED PROTEIN 3; INTERCELLULAR ADHESION MOLECULE 3; JANUS KINASE 2; LDHB PROTEIN; LEUCINE RICH REPEAT KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE 4; PDZ AND LIM DOMAIN 1; PEPTIDE TRANSPORTER 2; PEPTIDES AND PROTEINS; PRHOXNB PROTEIN; PROTEIN KINASE C ZETA; PROTEIN KINASE D; PROTEIN KINASE D1; SNORD80 PROTEIN; SPATA6 PROTEIN; THYROID HORMONE RECEPTOR ALPHA; TRANSPORT PROTEIN SEC61B; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR SUBFAMILY 9; UNCLASSIFIED DRUG; CYTOKINE; RNA;

ADULT; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; COLON MUCOSA; CROHN DISEASE; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOREGULATION; LEUKOCYTE MIGRATION; MALE; PATHOGENESIS; PRIORITY JOURNAL; ULCERATIVE COLITIS; COLON; GENETICS; GENOME-WIDE ASSOCIATION STUDY; INFLAMMATORY BOWEL DISEASE; INTESTINE MUCOSA; METABOLISM; MIDDLE AGED; SIGNAL TRANSDUCTION;

ADULT; CELL DIFFERENTIATION; CELL PROLIFERATION; COLON; CYTOKINES; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MALE; MIDDLE AGED; RNA; SIGNAL TRANSDUCTION;

EID: 84929893134     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000370     Document Type: Article

References (32)

1. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007;448:427-434.
2. Gaya DR, Russell RK, Nimmo ER, et al. New genes in inflammatory bowel disease: lessons for complex diseases? Lancet. 2006;367: 1271-1284.
3. Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491:119-124.
4. Franke A, McGovern DP, Barrett JC, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet. 2010;42:1118-1125.
5. Anderson CA, Boucher G, Lees CW, et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet. 2011;43:246-252.
6. Walsh T, McClellan JM, McCarthy SE, et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science. 2008;320:539-543.
7. Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545-15550.
8. Maglietta R, Piepoli A, Catalano D, et al. Statistical assessment of functional categories of genes deregulated in pathological conditions by using microarray data. Bioinformatics. 2007;23: 2063-2072.
9. Wang K, Li M, Hakonarson H. Analysing biological pathways in genomewide association studies. Nat Rev Genet. 2010;11:843-854.
10. Stoughton RB. Applications of DNA microarrays in biology. Annu Rev Biochem. 2005;74:53-82.
11. Lawrance IC, Fiocchi C, Chakravarti S. Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet. 2001;10:445-456.
12. Noble CL, Abbas AR, Cornelius J, et al. Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis. Gut. 2008;57:1398-1405.
13. Noble CL, Abbas AR, Lees CW, et al. Characterization of intestinal gene expression profiles in Crohn's disease by genome-wide microarray analysis. Inflamm Bowel Dis. 2010;16:1717-1728.
14. Langmann T, Moehle C, Mauerer R, et al. Loss of detoxification in inflammatory bowel disease: dysregulation of pregnane X receptor target genes. Gastroenterology. 2004;127:26-40.
15. Okahara S, Arimura Y, Yabana T, et al. Inflammatory gene signature in ulcerative colitis with cDNA macroarray analysis. Aliment Pharmacol Ther. 2005;21:1091-1097.
16. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989;170:2-6.
17. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol. 1995;57:289-300.
18. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402-508.
19. Abatangelo L, Maglietta R, Distaso A, et al. Comparative study of gene set enrichment methods. BMC Bioinformatics. 2009;10:275.
20. Good P. Permutation Tests: A Practical Guide to Resampling Methods for Testing Hypotheses (Springer Series in Statistics). New York: Springer; 2000.
21. Jogl G, Tong L. Crystal structure of carnitine acetyltransferase and implications for the catalytic mechanism and fatty acid transport. Cell. 2003; 112:113-122.
22. Bochukova E, Schoenmakers N, Agostini M, et al. A mutation in the thyroid hormone receptor alpha gene. N Engl J Med. 2012;366:243-249.
23. Eiseler T, Döppler H, Yan IK, et al. Protein kinase D1 regulates cofilinmediated F-actin reorganization and cell motility through slingshot. Nat Cell Biol. 2009;11:545-556.
24. Zha X, Wang F, Wang Y, et al. Lactate dehydrogenase B is critical for hyperactive mTOR-mediated tumorigenesis. Cancer Res. 2011;71:13-18.
25. Langmann T, Schmitz G. Loss of detoxification in inflammatory bowel disease. Nat Clin Pract Gastroenterol Hepatol. 2006;3:358-359.
26. de Vries HS, Te Morsche RH, Jenniskens K, et al. A functional polymorphism in UGT1A1 related to hyperbilirubinemia is associated with a decreased risk for Crohn's disease. J Crohns Colitis. 2012;6:597-602.
27. Cao Y, Dave KB, Doan TP, et al. Fatty acid CoA ligase 4 is up-regulated in colon adenocarcinoma. Cancer Res. 2001;61:8429-8434.
28. Monaco ME, Creighton CJ, Lee P, et al. Expression of long-chain fatty Acyl-CoA Synthetase 4 in breast and prostate cancers is associated with sex steroid hormone receptor negativity. Transl Oncol. 2010;3:91-98.
29. Sung YK, Hwang SY, Park MK, et al. Fatty acid-CoA ligase 4 is overexpressed in human hepatocellular carcinoma. Cancer Sci. 2003;94:421-424.
30. Cunningham MF, Docherty NG, Burke JP, et al. S100A4 expression is increased in stricture fibroblasts from patients with fibrostenosing Crohn's disease and promotes intestinal fibroblast migration. Am J Physiol Gastrointest Liver Physiol. 2010;299:G457-G466.
31. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. 2009;119:1420-1428.
32. Foell D, Wittkowski H, Roth J. Monitoring disease activity by stool analyses: from occult blood to molecular markers of intestinal inflammation and damage. Gut. 2009;58:859-868.